This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
opioid-use-disorder
Opioid Use Disorder
Opioid use disorder (~2.7M US; ~80K deaths/year fentanyl) involves μ-opioid-mediated VTA disinhibition → NAcc dopamine surge, tolerance, and LC rebound withdrawal; MOUD: buprenorphine, methadone, naltrexone; naloxone reverses overdose.
Entry Metadata
| Field | Value |
|---|---|
| ID | opioid-use-disorder |
| Name | Opioid Use Disorder |
| Status | draft |
| Last reviewed | 2026-06-08 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391-394. · PubMed 28723324
- Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207. · PubMed 24500948
- Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998;51(1-2):23-47. · PubMed 9716926